Evidence map›Paper›PMID 29295864›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2018

Harnessing an RNA-mediated chaperone for the assembly of influenza hemagglutinin in an immunologically relevant conformation.

Seung Won Yang, Yo Han Jang, Soon Bin Kwon, Yoon Jae Lee, Wonil Chae, Young Ho Byun, Paul Kim, Chan Park, Young Jae Lee, Choon Kang Kim and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. ABToxins · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Seung Won YangDepartment of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, South Korea.
Yo Han JangDepartment of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, South Korea.
Soon Bin KwonDepartment of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, South Korea.
Yoon Jae LeeDepartment of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, South Korea.
Wonil ChaeDepartment of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, South Korea.
Young Ho ByunDepartment of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, South Korea.
Paul KimDepartment of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, South Korea.
Chan ParkDepartment of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, South Korea.
Young Jae LeeDepartment of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, South Korea.
Choon Kang KimDepartment of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, South Korea.
Young Seok KimDepartment of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, South Korea.
Seong Il ChoiDepartment of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
Baik Lin SeongDepartment of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, South Korea.
Yonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel protein-folding function of RNA has been recognized, which can outperform previously known molecular chaperone proteins. The RNA as a molecular chaperone (chaperna) activity is intrinsic to some ribozymes and is operational during viral infections. Our purpose was to test whether influenza hemagglutinin (HA) can be assembled in a soluble, trimeric, and immunologically activating conformation by means of an RNA molecular chaperone (chaperna) activity. An RNA-interacting domain (RID) from the host being immunized was selected as a docking tag for RNA binding, which served as a transducer for the chaperna function for de novo folding and trimeric assembly of RID-HA1. Mutations that affect tRNA binding greatly increased the soluble aggregation defective in trimer assembly, suggesting that RNA interaction critically controls the kinetic network in the folding/assembly pathway. Immunization of mice resulted in strong hemagglutination inhibition and high titers of a neutralizing antibody, providing sterile protection against a lethal challenge and confirming the immunologically relevant HA conformation. The results may be translated into a rapid response to a new influenza pandemic. The harnessing of the novel chaperna described herein with immunologically tailored antigen-folding functions should serve as a robust prophylactic and diagnostic tool for viral infections.-Yang, S. W., Jang, Y. H., Kwon, S. B., Lee, Y. J., Chae, W., Byun, Y. H., Kim, P., Park, C., Lee, Y. J., Kim, C. K., Kim, Y. S., Choi, S. I., Seong, B. L. Harnessing an RNA-mediated chaperone for the assembly of influenza hemagglutinin in an immunologically relevant conformation.

Indexed as

Protein FoldingProtein MultimerizationAnimalsAntibodies, NeutralizingAntibodies, ViralFemaleHemagglutinin Glycoproteins, Influenza VirusImmunizationInfluenza A virusMiceMice, Inbred BALB CMolecular ChaperonesMutationRabbitsRNA, TransferAntibodies, NeutralizingAntibodies, ViralHemagglutinin Glycoproteins, Influenza Virushemagglutinin, human influenza A virusMolecular ChaperonesRNA, Transferchapernaneutralizing antibodyprotein foldingviral infection

Identifiers

PMID29295864
PMCPMC5901386
OpenAlexW2782291102

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.